Takeda Abbott Pharmaceuticals Sues Atrix
The Eligard products use Atrix's proprietary Atrigel sustained-release drug delivery technology, Atrix said. The liquid Eligard products are injected subcutaneously with a small gauge needle forming a solid implant in the body that slowly releases leuprolide as the implant is bioabsorbed.
Atrix chief executive David...
To view the full article, register now.